Statin use at the time of ovarian cancer surgery was associated with a 50% increase in the duration of progression-free survival and with more than a year of additional survival.

References and Resources
Elmore RG, et al. Impact of statin therapy on outcome in epithelial cancer. Gynecol Oncol. 2008; 108(suppl 1):S18.

Sponsored by The Doctor’s Channel